Literature DB >> 17607936

Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches.

Yan Wang1, Qun-Sheng Ji, Mark Mulvihill, Jonathan A Pachter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17607936     DOI： 10.1007/978-3-540-31209-3_5

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  10 in total

Review 1.  Progress of molecular targeted therapies for prostate cancers.

Authors:  Weihua Fu; Elena Madan; Marla Yee; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2011-11-29

Review 2.  Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

Authors:  Pushpendra Singh; Jimi Marin Alex; Felix Bast
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

Review 3.  Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.

Authors:  Jordi Rodon; Victoria DeSantos; Robert Jean Ferry; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

4.  Case series of dermatologic events associated with the insulin-like growth factor receptor 1 inhibitor cixutumumab.

Authors:  May Daher; Mario E Lacouture; Dana Rathkopf; Robert G Maki; Mary Louise Keohan; Bolorsukh Gansukh; Helen Chen; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

5.  Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

Authors:  Andrzej Badzio; Murry W Wynes; Rafal Dziadziuszko; Daniel T Merrick; Marta Pardo; Witold Rzyman; Anna Kowalczyk; Shalini Singh; James Ranger-Moore; Guadalupe Manriquez; Fabien Gaire; Jacek Jassem; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2010-12       Impact factor: 15.609

Review 6.  Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.

Authors:  Sylwia Ammoun; C Oliver Hanemann
Journal:  Nat Rev Neurol       Date:  2011-06-07       Impact factor: 42.937

Review 7.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

8.  Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.

Authors:  Brittany A Simone; Tu Dan; Ajay Palagani; Lianjin Jin; Sunny Y Han; Christopher Wright; Jason E Savage; Robert Gitman; Meng Kieng Lim; Juan Palazzo; Minesh P Mehta; Nicole L Simone
Journal:  Cell Cycle       Date:  2016-03-30       Impact factor: 4.534

9.  Cixutumumab-associated pancolitis in a patient with prostate cancer.

Authors:  Mehmet Asim Bilen; Jeri Kim; Huamin Wang; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2012-10-17       Impact factor: 2.872

10.  Caloric restriction augments radiation efficacy in breast cancer.

Authors:  Anthony D Saleh; Brittany A Simone; Juan Palazzo; Jason E Savage; Yuri Sano; Tu Dan; Lianjin Jin; Colin E Champ; Shuping Zhao; Meng Lim; Frederica Sotgia; Kevin Camphausen; Richard G Pestell; James B Mitchell; Michael P Lisanti; Nicole L Simone
Journal:  Cell Cycle       Date:  2013-05-21       Impact factor: 4.534
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.